Royce & Associates LP Buys New Position in Kewaunee Scientific Corporation $KEQU

Royce & Associates LP bought a new stake in shares of Kewaunee Scientific Corporation (NASDAQ:KEQU) in the 3rd quarter, HoldingsChannel reports. The firm bought 38,990 shares of the technology company’s stock, valued at approximately $1,663,000.

A number of other institutional investors have also recently made changes to their positions in KEQU. Minerva Advisors LLC raised its position in shares of Kewaunee Scientific by 5.0% during the 2nd quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company’s stock valued at $4,501,000 after buying an additional 3,677 shares in the last quarter. American Century Companies Inc. increased its stake in Kewaunee Scientific by 12.5% in the second quarter. American Century Companies Inc. now owns 55,310 shares of the technology company’s stock valued at $3,247,000 after acquiring an additional 6,128 shares during the last quarter. De Lisle Partners LLP raised its position in Kewaunee Scientific by 6.7% during the second quarter. De Lisle Partners LLP now owns 47,977 shares of the technology company’s stock valued at $2,811,000 after purchasing an additional 3,029 shares in the last quarter. Geode Capital Management LLC lifted its stake in Kewaunee Scientific by 0.9% during the second quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock worth $1,410,000 after purchasing an additional 223 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in Kewaunee Scientific by 125.7% during the first quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock worth $764,000 after purchasing an additional 10,803 shares during the last quarter. Institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Stock Performance

Kewaunee Scientific stock opened at $41.00 on Friday. The firm has a fifty day simple moving average of $39.54 and a two-hundred day simple moving average of $42.56. The company has a quick ratio of 1.71, a current ratio of 2.48 and a debt-to-equity ratio of 0.81. Kewaunee Scientific Corporation has a twelve month low of $30.33 and a twelve month high of $60.89. The company has a market capitalization of $117.67 million, a PE ratio of 10.41 and a beta of 0.56.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Wednesday, December 10th. The technology company reported $0.91 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.The firm had revenue of $70.10 million for the quarter. During the same period last year, the business posted $1.01 earnings per share.

Insider Buying and Selling

In other Kewaunee Scientific news, CEO Thomas David Hull III sold 2,177 shares of the business’s stock in a transaction that occurred on Wednesday, January 7th. The stock was sold at an average price of $37.50, for a total value of $81,637.50. Following the completion of the sale, the chief executive officer owned 33,000 shares in the company, valued at approximately $1,237,500. The trade was a 6.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last 90 days, insiders sold 4,719 shares of company stock valued at $179,028. 13.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Saturday, December 13th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Kewaunee Scientific has an average rating of “Hold”.

About Kewaunee Scientific

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.